FDA Clears SQI Diagnostics’s Automated Diagnostics Platform and RA Assay
SQI Diagnostics Inc, announced that the FDA has cleared the company’s automated SQiDworks Diagnostics Platform and its multiplexed IgXPLEX rheumatoid arthritis (RA) assay for marketing in the US.
Read More